Pharmacotherapy of Comorbid Mood, Anxiety, and Substance Use Disorders
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Mood and anxiety disorders commonly co-occur with substance use disorders. Exploration of the neurobiology of substance use disorders and mood and anxiety disorders have found that the neural circuitry in mood, anxiety, and substance use disorders is clearly overlapping. These discoveries have encouraged the exploration of a number of pharmacotherapeutic agents in the treatment of co-occurring mood, anxiety, and substance use disorders. In this article, recent data on the pharmacotherapeutic treatment of mood and anxiety disorders in individuals with substance use disorders are reviewed. Some of the barriers to the use of pharmacotherapy in individuals with substance use disorders are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.7 · Cited by 1,905
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585 · cited 2×
“Bupropion has well-documented efficacy in improving smoking cessation (Hurt et al., 1997; Jorenby et al., 1999), and depression (Zung et al., 1983).”
BackgroundKessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378 · cited 1×
“In both the ECA and the National Comorbidity Survey, bipolar disorder was the Axis I condition most commonly associated with a comorbid substance use disorder (Reiger et al., 1990; Kessler et al., 1996).”
BackgroundBohn, M. J., Babor, T. F., & Kranzler, H. R. (1995) · Journal of Studies on Alcohol · doi:10.15288/jsa.1995.56.423 · Cited by 1,356 · cited 1×
“Brief screening tools for substance use disorders that have been found useful in psychiatric settings include the Alcohol Use Identification Test (Bohn et al., 1995), and the Michigan Alcohol Screening Test and the Drug Abuse Screening Test (Cocco and Carey, 1998).”
MethodPsychiatric Diagnoses of Treatment-Seeking Cocaine Abusers
Rounsaville, B. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250045005 · Cited by 605
Posttraumatic stress disorder among substance users from the general population
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.5.664 · Cited by 479
Davidson, J. R. T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farfel, G. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.485 · Cited by 470
Compulsive Drug‐Seeking Behavior and Relapse: Neuroadaptation, Stress, and Conditioning Factors
WEISS, F., CICCOCIOPPO, R., PARSONS, L. H., KATNER, S., LIU, X., ZORRILLA, E. P., VALDEZ, G. R., BEN‐SHAHAR, O., ANGELETTI, S., & RICHTER, R. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03556.x · Cited by 430
Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
Hall, S. M., Reus, V. I., Muñoz, R. F., Sees, K. L., Humfleet, G., Hartz, D. T., Frederick, S., & Triffleman, E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.683 · Cited by 385
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1195 · Cited by 332 · cited 1×
“Modified versions of the SCID, such as the Psychiatric Research Interview for Substance and Mental Disorders, have been designed to develop the chronological relationships between the psychiatric symptom and substance use for the purpose of diagnostic clarity (Hasin et al., 1996).”
Method
Cited by
Sarris, J., Panossian, A., Schweitzer, I., Stough, C., & Scholey, A. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.04.002 · Cited by 469
Integrated treatment of substance use and psychiatric disorders
Kelly, T. M., & Daley, D. C. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.774673 · Cited by 378
“However, Brady and Verduin (2005) suggest that antidepressants should be considered in conjunction with psychotherapy, if GAD symptoms persist following detoxification.”
BackgroundTreatment of substance abusing patients with comorbid psychiatric disorders
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 284
Anxiety and alcohol use disorders: comorbidity and treatment considerations
Smith, J. (2012) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v34.4.06 · Cited by 255
Network Analysis and Precision Rehabilitation for the Post-concussion Syndrome
Iverson, G. L. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00489 · Cited by 121
Metadata
- Authors
- Brady, K. T., & Verduin, M. L.
- Venue
- Substance Use & Misuse
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 40
- Issue
- 13-14
- Pages
- 2021-2041
- ISSN
- 1082-6084 (ISSN-L)
- 1532-2491
- OpenAlex
- W2085654264
- Cited by
- 52
- References
- 16
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy of Comorbid Mood, Anxiety, and Substance Use Disorders. https://app.cochat.ai/papers/10.1080/10826080500294924
- The paper
- Brady, K. T., & Verduin, M. L. (2005). Pharmacotherapy of Comorbid Mood, Anxiety, and Substance Use Disorders. Substance Use & Misuse. https://doi.org/10.1080/10826080500294924
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.